Core Viewpoint - The company is holding its first extraordinary general meeting of shareholders in 2025 to discuss several key proposals, including the cancellation of the supervisory board, cash management using idle funds, and the election of a new board of directors [1][7][9]. Group 1: Meeting Proposals - Proposal 1 involves the cancellation of the supervisory board and amendments to the company's articles of association, with the supervisory board's powers being transferred to the audit committee of the board of directors [7][8]. - Proposal 2 seeks approval to use up to RMB 4 billion of temporarily idle funds for cash management, focusing on safe and liquid investment products [8][9]. - Proposal 3 is for the election of three non-independent directors to the third board of directors, with candidates nominated for the positions [9][10]. - Proposal 4 involves the election of three independent directors to the third board of directors, with candidates also nominated for these positions [11][12]. Group 2: Meeting Procedures - The meeting will be conducted with both on-site and online voting, with specific time slots for voting outlined [4][5]. - Shareholders must register and provide identification to participate, and only registered attendees can vote on-site [2][3]. - The meeting will follow a structured agenda, including the introduction of attendees, discussion of proposals, and voting [6][8].
安旭生物: 安旭生物2025年第一次临时股东大会会议资料